NCT03241875

Brief Summary

The aim of this study is to evaluate the effect of premedication with pregabalin or gabapentin versus placebo on postoperative shoulder pain after laparoscopic cholecystectomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Dec 2016

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 29, 2017

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 8, 2017

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2017

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 28, 2017

Completed
Last Updated

October 2, 2017

Status Verified

September 1, 2017

Enrollment Period

9 months

First QC Date

July 29, 2017

Last Update Submit

September 28, 2017

Conditions

Keywords

pregabalingabapentinpost operative painlaparoscopic cholecystectomy

Outcome Measures

Primary Outcomes (1)

  • Post operative shoulder pain

    Primary outcome is the intensity of shoulder pain during the first 48 hours after laparoscopic cholecystectomy using the visual analog scale (VAS).

    VAS score with rest at 2h, 6h, 12h, 24h and 48 hours after surgery

Secondary Outcomes (3)

  • remifentanil consumption during anesthesia

    one hour after tracheal tube removal

  • Post operative sleep quality during the first night

    first night after surgery

  • Post operative nausea and vomiting

    2, 6, 12, 24 and 48 hours after surgery.

Study Arms (3)

placebo

PLACEBO COMPARATOR

Patients receive 2 capsules as placebo 2 hours before anesthesia. The capsules are delivered by the hospital pharmacy.

Drug: Placebo oral capsule

pregabalin

EXPERIMENTAL

patients receive 2 capsules of pregabalin (pregabalin 75), two hours before anesthesia.

Drug: Pregabalin 75mg

gabapentin

EXPERIMENTAL

patients receive 2 capsules of gabapentin (gabapentin 300), two hours before anesthesia.

Drug: Gabapentin 300mg

Interventions

In this group, premedication is performed with 2 capsules of pregabalin 2 hours before anesthetic induction.

pregabalin

In this group, premedication is performed with 2 capsules of gabapentin 2 hours before anesthetic induction.

gabapentin

In this group, no premedication is performed, but patients receive 2 capsules of placebo 2 hours before anesthetic induction.

Also known as: placebo
placebo

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • uncomplicated laparoscopic cholecystectomy
  • American Society of Anesthesiologists (ASA) status \< 3

You may not qualify if:

  • acute cholecystitis
  • conversion to open cholecystectomy
  • history of epilepsia, psychiatric disorders and cognitive impairment
  • Pregnancy and breastfeeding
  • allergy to pregabalin and/or gabapentin
  • Chronic pain
  • Chronic medication by corticosteroids, neuroleptics or non steroidal anti inflammatory drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sahloul Teaching Hospital

Sousse, 4054, Tunisia

Location

Related Publications (4)

  • Tiippana EM, Hamunen K, Kontinen VK, Kalso E. Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety. Anesth Analg. 2007 Jun;104(6):1545-56, table of contents. doi: 10.1213/01.ane.0000261517.27532.80.

  • Valadan M, Banifatemi S, Yousefshahi F. Preoperative Gabapentin to Prevent Postoperative Shoulder Pain After Laparoscopic Ovarian Cystectomy: A Randomized Clinical Trial. Anesth Pain Med. 2015 Dec 5;5(6):e31524. doi: 10.5812/aapm.31524. eCollection 2015 Dec.

  • Agarwal A, Gautam S, Gupta D, Agarwal S, Singh PK, Singh U. Evaluation of a single preoperative dose of pregabalin for attenuation of postoperative pain after laparoscopic cholecystectomy. Br J Anaesth. 2008 Nov;101(5):700-4. doi: 10.1093/bja/aen244. Epub 2008 Aug 20.

  • Nakhli MS, Kahloul M, Jebali C, Frigui W, Naija W. Effects of Gabapentinoids Premedication on Shoulder Pain and Rehabilitation Quality after Laparoscopic Cholecystectomy: Pregabalin versus Gabapentin. Pain Res Manag. 2018 Jul 9;2018:9834059. doi: 10.1155/2018/9834059. eCollection 2018.

MeSH Terms

Conditions

Pain, Postoperative

Interventions

PregabalinGabapentin

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

gamma-Aminobutyric AcidAminobutyratesButyratesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsAmino AcidsAmino Acids, Peptides, and ProteinsAminesCyclohexanecarboxylic AcidsAcids, CarbocyclicCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbons

Study Officials

  • Mohamed Said Nakhli, MD

    Faculty of Medicine, Sousse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, anesthesia and intensive care

Study Record Dates

First Submitted

July 29, 2017

First Posted

August 8, 2017

Study Start

December 1, 2016

Primary Completion

August 30, 2017

Study Completion

September 28, 2017

Last Updated

October 2, 2017

Record last verified: 2017-09

Locations